Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL7AP20, ribosomal protein L7a pseudogene 20, is a processed pseudogene found in the human genome and named in reference to the ribosomal protein L7a gene, which encodes a protein involved in the large (60S) ribosomal subunit and plays a role in protein synthesis[1][3][2]. Unlike its parent gene (RPL7A), RPL7AP20 does not encode a functional protein and is one of many similar pseudogenes present in the genome[9][3]. Consequently, it does not serve as a receptor, enzyme, transporter, or established therapeutic target[3][8][10]. In current literature and gene databases, there are no reports of direct disease involvement, biological function, drug interactions, mechanisms of action, biomarker utility, or safety issues associated with RPL7AP20 specifically[3][8][10].
No mechanism; it is not a therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 20 (RPL7AP20).